Ionis Pharmaceuticals reported $27.11M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 19.93M 3.58M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Arrowhead Research USD 30.15M 2.37M Sep/2026
Astellas Pharma JPY 187.58B 4.7B Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Celltrion KRW 89.12B 534.9M Jun/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Divis Laboratories Ltd INR 17.59B 5.48B Sep/2026
Exelixis USD 30.83M 8.23M Sep/2026
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
Kangmei Pharma CNY 2.27B 185.33M Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Moderna USD 259M 92M Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Neurocrine Biosciences USD 754.1M 612.1M Sep/2026
Novartis USD 4.24B 15M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
OPKO Health USD 50.04M 5.87M Jun/2026
Organigram Holdings CAD 99.93M 26.79M Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pfizer USD 4.07B 511M Sep/2026
Pharma Mar EUR 50.62M 11.69M Sep/2026
PTC Therapeutics USD 41.59M 1.14M Sep/2026
Qiagen NV USD 79.08M 785K Jun/2026
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sarepta Therapeutics USD 45.7M 5.28M Sep/2026
Sartorius EUR 324.8M 4.3M Sep/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tilray USD 114.5M 3.69M Sep/2025
Ultragenyx Pharmaceutical USD 45M 6M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026
Zealand Pharma A/S 171M 175.6M Mar/2026
Zz Pientze Pharmaceu CNY 548.5M 76.78M Sep/2026